All of WSIPP's research is published on our website. The Publications page includes every report we've released—from our founding in 1983 to the present. Each report entry includes the title, publication date, abstract, any available supplemental materials, and a downloadable PDF.
WSIPP reports are not updated after publication, and any report older than two years is designated with an “Archived” label.
To explore our benefit-cost and meta-analytic findings, please visit the Benefit-Cost section of the website.
Use the search fields below to find specific publications that match certain criteria. If you want to find other information on our website that is not publications, you can use the search field in the navigation bar at the top, or click here to search the entire website.
Found 1 results
The Chemical Dependency Disposition Alternative (CDDA) was created by the 1997 Washington State Legislature as a sentencing option for juvenile offenders. The goal was to reduce recidivism by providing treatment for chemically dependent or substance abusing youth. The Institute was directed by the 1997 Legislature to evaluate CDDA to determine its impacts on recidivism. The Institute surveyed the courts to determine how to identify both the CDDA and the CDDA comparison groups. After the initial phase of data collection, the Institute found that an appropriate comparison group could not be identified. Thus, it was not possible to evaluate the impact of CDDA on recidivism or conduct a cost-benefit analysis. However, the survey revealed variations in the implementation of CDDA across the state.